Clinical Trial Update: Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage [Phase 3]

View source ↗

Summary

Phase 3 trial update on using lactulose to prevent hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Portal-systemic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)

Snippet

Sponsor: Aga Khan University | Conditions: Hepatocerebral Encephalopathy, Portal-Systemic Encephalopathy | Phase 3 | Status: UNKNOWN